BellRing Brands Q4 Earnings Slip, But Sales Improve; Stock Up Over 16% In Pre-Market
BellRing Brands (BRBR) reported Q4 2026 earnings of $35.6M ($0.31/share), down from $59.6M ($0.48/share) a year ago. Sales rose to $692M, up from $648.2M, driven by volume growth. Premier Protein sales increased 7.1%. The company expects fiscal 2027 adjusted EBITDA of $310M-$350M and sales of $2.32B-$2.42B. BRBR stock rose 16.21% in pre-market trading.
How this was made

The 30-second read
Why it matters
Traders will likely focus on the gap between rising sales and falling profitability, and whether the FY2027 adjusted EBITDA and net sales ranges imply margin stabilization after the inventory-related headwind.
Market read
A same-day earnings and guidance print with explicit FY2027 ranges, plus a large pre-market move, creates a tradable setup around margin expectations.
What to watch
The article highlights price/mix decline (8.1% lower) alongside volume growth, which can foreshadow weaker profitability if promotional intensity persists.
Background
BellRing Brands is a consumer brands company with a key product line in Premier Protein; this is its Q4 FY2026 earnings update and FY2027 outlook.
Ticker impact
BellRing Brands reported Q4 FY2026 net profit of $35.6M vs $59.6M prior year, while net sales rose to $692M, plus FY2027 EBITDA and sales guidance.
Likely near-term support from the sales increase and provided FY2027 guidance, but upside may be capped by the earnings and EBITDA decline.
The article contains both the earnings deterioration (profit, operating income, adjusted EBITDA, COGS) and the offsetting positives (net sales growth, volume gains, and explicit FY2027 adjusted EBITDA and net sales ranges).
Market effects
Signals ongoing margin pressure in consumer packaged goods/health nutrition brands, even when volumes hold up.
Primarily US consumer staples sentiment, with limited direct regional spillover implied by the single-company print.
Low, as the disclosure is company-specific and not tied to global macro or cross-border policy changes.
Counterpoint
The pre-market pop may overreact to revenue growth and guidance ranges, while the underlying margin deterioration (higher COGS, inventory headwind) could reassert itself in subsequent quarters.
Key entities
- companyBellRing Brands, Inc.
Reported Q4 FY2026 earnings decline with sales growth, and provided FY2027 adjusted EBITDA and net sales guidance.
- product_linePremier Protein
Premier Protein net sales increased, driven by volume growth but with price/mix decline.



